Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Biotechnology Reagents & Kits Market Growth is Driven by Advancements in Molecular Biology, Personalized Medicine, and Automation; North America and Asia-Pacific Lead Regional Expansion.Austin, United ...

Scientists have long been trying to tease apart hepatitis A virus, to understand its inner workings and how it functions in the human body. Infectious disease researchers have discovered that a little ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

These therapies are designed to combat antibody-producing cells ... s unbiased sequencing approach accurately identifies ...

The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 25+ companies and 30+ ...

New research has illustrated how hepatitis A virus uses cellular proteins, like PDAP1, to infect liver cells, replicate and ...

Recall that scientists developed CRISPR-Cas9 based on a unique mechanism in ... We are using biological therapies such as protein vaccines, antibodies, and enzymes to treat a variety of diseases ...

The deal focuses on the development of degrader-antibody conjugates (DACs), a fairly ... which became the first based on the CRISPR/Cas9 gene-editing technology to be approved towards the end ...

When Delgado-Benito removed PDAP1 from cells in the lab, the immune cells died of stress and were not able to produce their ...